Citigroup
NXTC icon

Citigroup’s NextCure NXTC Stock Holding History

Citigroup’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$61.5K Buy
+12,284
New +$68.4K ﹤0.01% 4637
2026
Q2 		– Sell
-1
Closed -$11 – 6095
2026
Q1 		$11 Buy
+1
New +$12 ﹤0.01% 5733
2025
Q4 		– Sell
-1
Closed -$6 – 6339
2025
Q3 		$6 Sell
1
-85,455
-100% -$447K ﹤0.01% 5974
2025
Q2 		$472K Sell
85,456
-32,825
-28% -$176K ﹤0.01% 3662
2025
Q1 		$682K Buy
118,281
+2,528
+2% +$22.3K ﹤0.01% 3511
2024
Q4 		$1.07M Buy
+115,753
New +$1.7M ﹤0.01% 3307
2022
Q4 		– Sell
-27
Closed -$1K – 5902
2022
Q3 		$1K Sell
27
-8
-23% -$408 ﹤0.01% 5658
2022
Q2 		$2K Sell
35
-15
-30% -$783 ﹤0.01% 5905
2022
Q1 		$3K Sell
50
-20
-29% -$1.25K ﹤0.01% 5970
2021
Q4 		$5K Sell
70
-52
-43% -$4.35K ﹤0.01% 5662
2021
Q3 		$10K Sell
122
-27
-18% -$2.37K ﹤0.01% 5469
2021
Q2 		$14K Sell
149
-266
-64% -$27.2K ﹤0.01% 5506
2021
Q1 		$50K Sell
415
-294
-41% -$42.6K ﹤0.01% 4711
2020
Q4 		$93K Buy
709
+603
+569% +$77.9K ﹤0.01% 5592
2020
Q3 		$12K Sell
106
-396
-79% -$48.7K ﹤0.01% 6506
2020
Q2 		$130K Sell
502
-202
-29% -$76.9K ﹤0.01% 5354
2020
Q1 		$314K Sell
704
-62
-8% -$33.1K ﹤0.01% 4314
2019
Q4 		$518K Buy
766
+754
+6,283% +$378K ﹤0.01% 4391
2019
Q3 		$4K Sell
12
-55
-82% -$17.9K ﹤0.01% 7396
2019
Q2 		$12K Buy
+67
New +$13.9K ﹤0.01% 7256

Other funds holding NXTC

Affinity Asset Advisors
Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $18B AUM 27.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Pfizer
Pfizer New York $164M AUM 53.62% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Citigroup's NXTC Position: Q3 2026 in Review

Citigroup opened a new position in NextCure (NXTC) in Q3 2026: 12,284 shares worth $61.5K. The stake represents ﹤0.01% of the portfolio and ranks #4637 among its holdings. This is a return to the name: Citigroup previously reported a position in NXTC as recently as Q1 2026.

Citigroup first reported a position in NXTC in Q2 2019 and has held it in 20 quarters since. The position peaked at $1.07M in Q4 2024. 21 funds tracked by Wall St. Rank hold NXTC as of Q3 2026.

  • Citigroup held 12,284 shares of NextCure worth $61.5K as of Q3 2026.
  • NextCure was a new Citigroup position in Q3 2026.
  • NextCure made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #4637 holding.
  • Citigroup first reported a position in NextCure in Q2 2019 and has held it in 20 quarters since.
  • Citigroup's NextCure position peaked at $1.07M in Q4 2024.
  • 21 funds tracked by Wall St. Rank held NextCure as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.